| scholarly article | Q13442814 |
| P50 | author | Ruth Faden | Q7382971 |
| Matthew DeCamp | Q38326756 | ||
| Steven Joffe | Q44378576 | ||
| Conrad V Fernandez | Q90710197 | ||
| P2093 | author name string | Yoram Unguru | |
| P2860 | cites work | The U.S. pediatric cancer clinical trials programmes: international implications and the way forward | Q28251920 |
| Principles for allocation of scarce medical interventions | Q28308058 | ||
| Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia | Q33711119 | ||
| Track-and-Trace Drug Verification: FDA Plans New National Standards, Pharmacies Tread With Trepidation. | Q34906704 | ||
| The drug shortage crisis in the United States: causes, impact, and management strategies | Q35752900 | ||
| Ethical challenges: managing oncology drug shortages | Q36678216 | ||
| Coping with critical drug shortages: an ethical approach for allocating scarce resources in hospitals | Q38046089 | ||
| Responding to the immunoglobulin shortage: a case study | Q40607936 | ||
| Prices gone wild: grey market 'scalpers' scoring windfall in American drug market | Q43072525 | ||
| National survey on the effect of oncology drug shortages on cancer care | Q43435019 | ||
| The shortage of essential chemotherapy drugs in the United States. | Q44970326 | ||
| Ten strategies to lower costs, improve quality, and engage patients: the view from leading health system CEOs. | Q45956948 | ||
| Unpredictable drug shortages: an ethical framework for short-term rationing in hospitals | Q48502739 | ||
| Social justice in pandemic preparedness. | Q52999525 | ||
| Ethical framework for resource allocation during a drug supply shortage | Q58665668 | ||
| Drug shortages--a critical challenge for the generic-drug market | Q82270947 | ||
| Chemotherapy drug shortages in the United States: genesis and potential solutions | Q83365320 | ||
| Drug shortages delay cancer clinical trials | Q84416681 | ||
| Impact of drug shortages on U.S. health systems | Q84963966 | ||
| The impact of drug shortages on children with cancer--the example of mechlorethamine | Q85791041 | ||
| Economic and technological drivers of generic sterile injectable drug shortages | Q85931594 | ||
| Substitution with doxorubicin for daunorubicin during induction for high risk pediatric acute lymphoblastic leukemia results in increased toxicity | Q87384055 | ||
| Drug shortage-associated increase in catheter-related blood stream infection in children | Q87418265 | ||
| The drugs stop here: a public health framework to address the drug shortage crisis | Q95564829 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemotherapy | Q974135 |
| drug shortage | Q94443615 | ||
| P304 | page(s) | e716-24 | |
| P577 | publication date | 2014-03-01 | |
| P1433 | published in | Pediatrics | Q7159238 |
| P1476 | title | Chemotherapy drug shortages in pediatric oncology: a consensus statement | |
| P478 | volume | 133 |
| Q38366900 | An ethical framework for responding to drug shortages in pediatric oncology |
| Q88320356 | Cancer drug shortages: Awareness and perspectives from a representative sample of the US population |
| Q49142488 | Chemotherapy drug shortages in paediatric oncology: A 14-year single-centre experience in Belgium. |
| Q28082623 | Development of biosimilars in an era of oncologic drug shortages |
| Q89571352 | Drug Shortages: The View Across an Ocean |
| Q35566369 | Drug shortages and implications for pediatric patients |
| Q90735469 | Global Access to Essential Medicines for Childhood Cancer: A Cross-Sectional Survey |
| Q91637220 | Identification and Resolution of Drug-Related Problems among Childhood Cancer Patients in Ethiopia |
| Q38604722 | Physician approaches to drug shortages: Results of a national survey of pediatric hematologist/oncologists |
| Q38810911 | Precision medicine in pediatric oncology: Lessons learned and next steps |
| Q38253579 | Scientific, economic, regulatory, and ethical challenges of bringing science-based pediatric nutrition products to the U.S. market and ensuring their availability for patients |
| Q36347871 | The impact of chemotherapy shortages on COG and local clinical trials: a report from the Children's Oncology Group |
| Q41925961 | U.S. vaccine and immune globulin product shortages, 2001-15. |
| Q51059873 | Using decision modeling to guide drug allocation during a shortage. |
Search more.